These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 14575013)

  • 41. Secondary prevention for ischemic heart disease. Relative numbers needed to treat with different therapies.
    Miller DB
    Arch Intern Med; 1997 Oct; 157(18):2045-52. PubMed ID: 9382659
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF): rationale and design.
    Fonarow GC; Abraham WT; Albert NM; Gattis WA; Gheorghiade M; Greenberg B; O'Connor CM; Yancy CW; Young J
    Am Heart J; 2004 Jul; 148(1):43-51. PubMed ID: 15215791
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [New beta-blockers in the treatment of chronic ischaemic heart disease].
    Jankowski P; Kawecka-Jaszcz K; Jastrzebski M
    Przegl Lek; 2004; 61(9):955-61. PubMed ID: 15803908
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Secondary prevention of ischemic heart disease. A questionnaire study and suggestions to improved cooperation between hospitals and general practice].
    Bech J; Helqvist S; Hansen H; Friis J; Jacobsen J; Hildebrandt PR
    Ugeskr Laeger; 1999 Jun; 161(24):3650-4. PubMed ID: 10485222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical presentation and pharmacological therapy in patients with cardiogenic pulmonary oedema.
    Fiutowski M; Waszyrowski T; Krzemińska-Pakuła M; Kasprzak JD
    Kardiol Pol; 2004 Dec; 61(12):561-9; discussion 570. PubMed ID: 15815756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Outcome of patients with acute myocardial infarction admitted in hospitals with or without catheterization laboratory: results from the HELIOS registry.
    Pipilis A; Andrikopoulos G; Lekakis J; Kalantzi K; Kitsiou A; Toli K; Floros D; Gaita D; Karalis I; Dragomanovits S; Kalogeropoulos P; Synetos A; Koutsogiannis N; Stougiannos P; Antonakoudis C; Goudevenos J;
    Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):85-90. PubMed ID: 19188809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effect of long-term cardiac training on lipids concentration in patients with chronic heart ischemic disease treated with simvastatin].
    Kałka D; Sobieszczańska M; Kopka L; Marciniak W; Zawadzka-Bartczak E; Bak A; Popielewicz-Kautz A; Korzeniowska J; Janczak J; Adamus J
    Pol Merkur Lekarski; 2007 Feb; 22(128):101-6. PubMed ID: 17598652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of mortality after discharge in patients hospitalized with heart failure: an analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF).
    O'Connor CM; Abraham WT; Albert NM; Clare R; Gattis Stough W; Gheorghiade M; Greenberg BH; Yancy CW; Young JB; Fonarow GC
    Am Heart J; 2008 Oct; 156(4):662-73. PubMed ID: 18926148
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
    Davis BR; Piller LB; Cutler JA; Furberg C; Dunn K; Franklin S; Goff D; Leenen F; Mohiuddin S; Papademetriou V; Proschan M; Ellsworth A; Golden J; Colon P; Crow R;
    Circulation; 2006 May; 113(18):2201-10. PubMed ID: 16651474
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Coronary risk factors and mode of ischemic heart disease treatment in patients over 65 years of age].
    Chizyński K
    Przegl Lek; 2003; 60(7):451-5. PubMed ID: 14750417
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Intervention program to improve secondary prevention of myocardial infarction. Results of the PRESENTE (early secondary prevention) study].
    de Velasco JA; Cosín J; de Oya M; de Teresa E;
    Rev Esp Cardiol; 2004 Feb; 57(2):146-54. PubMed ID: 14967110
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Two year follow-up of acute ischemic syndrome without ST elevation].
    Tan HQ; Zhu J; Liang Y; Zhang Y; Liu LS;
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(3):184-8. PubMed ID: 15854465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Epidemiologic evaluation of cardiac decompensation and its impact on health costs].
    Bilora F; Vettore G; Saccaro G; Barbata A; Dei Rossi C; Petrobelli F
    Minerva Cardioangiol; 1998; 46(7-8):235-9. PubMed ID: 9973786
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primary and secondary prevention of ischemic heart disease.
    Bittner V
    Curr Opin Cardiol; 1994 Jul; 9(4):417-27. PubMed ID: 7919586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determinants of poor hypertension management in patients with ischaemic heart disease.
    Jankowski P; Kawecka-Jaszcz K; Bilo G; Pajak A
    Blood Press; 2005; 14(5):284-92. PubMed ID: 16257874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Treatment of the acute coronary syndrome in Germany: experiences in a German cluster of the GRACE registry].
    Tebbe U; Bramlage P; von Löwis of Menar P; Lawall H; Gaudron P; Lüders S; Klaus A; Lengfelder W; Scholz KH; Maziejewski S; Cuneo A; Hohmann V; Gulba D
    Dtsch Med Wochenschr; 2007 Sep; 132(39):2000-5. PubMed ID: 17882737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Secondary prevention of ischemic heart disease: pharmacological treatment after myocardial infarction according to follow-up protocol].
    Milvidaite I; Luksiene D; Slapikiene B; Babarskiene MR; Liukaitis V; Maciulaitis R; Kadusevicius E; Pilviniene R
    Medicina (Kaunas); 2007; 43(2):131-6. PubMed ID: 17329948
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Prevention secondary to ischemic cardiopathy at the lipid level in primary care in Aragon. PRECIAR study 1].
    Martínez Hernández AA; Aguilar Leñero MJ; Rabadán Mengíbar M; Hernansanz Iglesias F; González Ramos J; Marín Obáñez A
    Rev Esp Salud Publica; 2001; 75(2):143-9. PubMed ID: 11400424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.